Claret Asset Management Corp Pfizer Inc Transaction History

Claret Asset Management Corp

$839 Million
Q3 2025

A detailed history of Claret Asset Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Claret Asset Management Corp holds 283,977 shares of PFE stock, worth $7.12 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

283,977

Previous 308,522 7.96%

Holding current value

$7.12 Million

Previous $7.48 Million 3.25%

% of portfolio

0.86%

Previous 0.97%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$23.29 - $25.88 $571,653 - $635,224	-24,545 Reduced 7.96%	283,977 $7.24 Million
Q2 2025 Aug 13, 2025	BUY	$21.59 - $24.84 $339,589 - $390,708	15,729 Added 5.37%	308,522 $7.48 Million
Q1 2025 May 13, 2025	SELL	$25.01 - $27.13 $77,505 - $84,075	-3,099 Reduced 1.05%	292,793 $7.42 Million
Q4 2024 Feb 13, 2025	BUY	$24.8 - $30.19 $4.35 Million - $5.29 Million	175,273 Added 145.31%	295,892 $7.85 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $24,625 - $27,905	-889 Reduced 0.73%	120,619 $3.49 Million

Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $44,078 - $51,652	-1,745 Reduced 1.42%	121,508 $3.4 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $759,949 - $872,664	29,353 Added 31.26%	123,253 $3.42 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $2.24 Million - $2.92 Million	85,911 Added 1075.37%	93,900 $2.7 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $16,815 - $19,655	524 Added 7.02%	7,989 $265,000
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $6,754 - $7,814	187 Added 2.57%	7,465 $274,000
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $1,969 - $2,564	50 Added 0.69%	7,278 $297,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $8,725 - $11,390	209 Added 2.98%	7,228 $370,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $24,068 - $29,381	550 Added 8.5%	7,019 $307,000
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $3,396 - $4,027	-73 Reduced 1.12%	6,469 $339,000
Q1 2022 Apr 04, 2022	BUY	$45.75 - $56.69 $15,051 - $18,651	329 Added 5.3%	6,542 $339,000
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $8,470 - $12,556	-205 Reduced 3.19%	6,213 $367,000
Q3 2021 Dec 02, 2021	SELL	$39.25 - $50.42 $142,752 - $183,377	-3,637 Reduced 36.17%	6,418 $276,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $1,256 - $1,423	35 Added 0.35%	10,055 $394,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $25,050 - $28,251	-748 Reduced 6.95%	10,020 $363,000
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $1.43 Million - $1.82 Million	-42,646 Reduced 79.84%	10,768 $396,000
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $15,875 - $18,625	-500 Reduced 0.93%	53,414 $1.96 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $115,811 - $140,496	3,845 Added 7.68%	53,914 $1.76 Million
Q1 2020 Apr 06, 2020	BUY	$27.03 - $38.62 $279,219 - $398,944	10,330 Added 25.99%	50,069 $1.63 Million
Q4 2019 Jan 07, 2020	SELL	$32.92 - $37.36 $23,076 - $26,189	-701 Reduced 1.73%	39,739 $1.56 Million
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $4,418 - $5,729	-136 Reduced 0.34%	40,440 $1.45 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $3,439 - $3,861	-93 Reduced 0.23%	40,576 $1.76 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $15,937 - $17,510	-425 Reduced 1.03%	40,669 $1.73 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $38,931 - $44,386	-1,012 Reduced 2.4%	41,094 $1.79 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $44,673 - $54,185	1,296 Added 3.18%	42,106 $1.86 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $33,507 - $35,722	-1,016 Reduced 2.43%	40,810 $1.48 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $446 - $518	-14 Reduced 0.03%	41,826 $1.48 Million
Q4 2017 Mar 27, 2018	BUY	$33.26 - $35.29 $1.39 Million - $1.48 Million	41,840	41,840 $1.52 Million

Others Institutions Holding PFE

# of Institutions

3,356

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account

Claret Asset Management Corp Pfizer Inc Transaction History